"Up the Price by How Much?"

Turing Pharmaceutical's CEO has backed down on the 4000% price hike for Daraprim, but is the damage done? Take our poll.

You’ve read about Turing Pharmaceuticals’ recent attempt to increase the cost of Daraprim by about 4000%.  

Do you think this move is:

A. Legitimate: funds will help subsidize new drug development
B. Motivated purely by financial gain and a harbinger of more to come
C. Not new: others have done it
D. A swan song: public and political pressure will stop this from becoming a trend
E. A priority issue for 2016 presidential candidates
F. Other
Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
© 2023 MJH Life Sciences

All rights reserved.